Center for scientific review (CSR) software development and technical support

Active Awarded Last action

Contract number
75N92023F00001
Awardee
Awarding agency
Obligated
$18,187,975

Award facts

Contract value 62% obligated
  • $24,930,340.10 Current, with exercised options
  • $29,275,749.78 Potential, with all options
Completion date 69% complete
  • Current, with exercised options
  • Potential, with all options
Funding agency
Center for Scientfic Review National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Time and Materials
Place of performance
Reston, VA 20190, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00006 -$342,373
Supplemental Agreement for work within scope P00004 $690,471
Exercise an Option P00003 $5,342,922
Exercise an Option P00002 $6,309,887
Funding Only Action P00001 $479,646
Original award $5,707,422

About this award

The National Institutes of Health Center for Scientific Review issued a delivery order to Leidos, Inc. on July 1, 2023, under the CIO-SP3 GWAC for software development and technical support, with a $29.3 million ceiling and time-and-materials pricing.

CIO-SP3 is a GSA-administered GWAC supporting IT modernization and solutions across federal agencies. Place of performance is Reston, VA. Ultimate completion is April 10, 2028.

The order funds software development and technical support services for CSR operations. No set-aside was used.

Government-invoiced labor across the award reached $6.3 million in FY2025, supported by 35.1 FTEs delivering 73,021 contractor hours at a blended rate of $86.31 per hour. FY2024 invoiced labor was $6 million across 33.7 FTEs and 70,055 hours at $86.00 per hour. FY2023, the first reported year, generated $1.7 million in invoiced labor across 9.1 FTEs and 18,903 hours at $88.91 per hour, reflecting ramp-up through the initial period. In FY2025, 10 percent of contractor hours were performed by 2 subcontractors. Pricing and labor utilization have remained roughly flat year-over-year since FY2024.

Quick answers

Who was awarded contract 75N92023F00001?

75N92023F00001 was awarded to Leidos, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on July 1, 2023.

How much is contract 75N92023F00001 worth?

The government has obligated $18,187,975 on 75N92023F00001. Its current value, with exercised options, is $24,930,340. Its potential value, with all options, is $29,275,750.

Which agency awarded contract 75N92023F00001?

National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92023F00001, with funding from Center for Scientfic Review (National Institutes of Health).

Is contract 75N92023F00001 an order under another contract?

Yes. 75N92023F00001 is a delivery order under HHSN316201200044W, a government wide acquisition contract (GWAC), on Chief Information Officer - Solutions and Partners 3 (CIO-SP3).

Was contract 75N92023F00001 competed?

The extent of competition for 75N92023F00001 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award